![Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells | The EMBO Journal Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells | The EMBO Journal](https://www.embopress.org/cms/asset/a1702c60-fae3-4415-b29e-2cdb3c6cb66b/embj201797980-abs-0001-m.jpg)
Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells | The EMBO Journal
![Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/8/2/e001073/F4.large.jpg)
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer
![Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies](https://www.frontiersin.org/files/Articles/495638/fimmu-10-02664-HTML/image_m/fimmu-10-02664-g001.jpg)
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
![Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abc6401/asset/66a1288a-faa5-4f7c-8c34-872fd80694d0/assets/graphic/abc6401-f1.jpeg)
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig2_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
![Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model](https://www.frontiersin.org/files/Articles/478945/fimmu-10-02680-HTML/image_m/fimmu-10-02680-g001.jpg)
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
![A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9c3e4a4c-083a-437a-95cf-ca2f05cd169b/eji3979-gra-0001-m.png)
A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library
![Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram](https://www.researchgate.net/publication/323911459/figure/fig1/AS:606619687714816@1521640812005/Summary-of-CD19-and-CD20-expression-during-B-cell-development-CD19-expression-is.png)